Status and phase
Conditions
Treatments
About
To determine the safety and tolerability of multiple ascending fixed oral doses of SRA-333 in subjects with mild to moderate Alzheimer's disease.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other exclusions apply
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal